Peroxisome proliferator-activated receptor γ in malignant diseases

Critical Reviews in Oncology/Hematology

Volumn 58, Issue 1, 2006, Pages 1-14

  Wang, Tingting ^a   Xu, Jian ^b   Yu, Xiaofei ^a   Yang, Renchi ^a   Han, Zhong Chao ^a  

^a INSTITUTE OF HEMATOLOGY AND BLOOD DISEASES HOSPITAL   (China)

^b CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

Leukemia; Ligands; PPAR ; Solid cancer

Indexed keywords

CIGLITAZONE; FENOPROFEN; GLITAZONE DERIVATIVE; IBUPROFEN; INDOMETACIN; NONSTEROID ANTIINFLAMMATORY AGENT; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PIOGLITAZONE; PROTEIN BAX; PROTEIN P18; PROTEIN P21; PROTEIN P27; RETINOIC ACID; ROSIGLITAZONE; TROGLITAZONE;

ANGIOGENESIS; ANTINEOPLASTIC ACTIVITY; ARTICLE; BONE MARROW CELL; BREAST CANCER; CANCER CELL; CELL CYCLE; CELL GROWTH; CELL PROLIFERATION; DNA BINDING; DRUG EFFECT; HUMAN; MYELOPROLIFERATIVE DISORDER;

EID: 33644954823     PISSN: 10408428     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.critrevonc.2005.08.011     Document Type: Review

References (146)

1. J. Vamecq, and N. Latruffe Medical significance of peroxisome proliferator-activated receptors Lancet 354 1999 141 148
2. I. Issemann, and S. Green Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators Nature 347 1990 645 650
3. O. Braissant, F. Foufelle, C. Scotto, M. Dauca, and W. Wahli Differential expression of peroxisome proliferator-activated receptors (PPARs): tissue distribution of PPAR-alpha, -beta, and -gamma in the adult rat Endocrinology 137 1996 354 366
4. S.A. Kliewer, B.M. Forman, and B. Blumberg Differential expression and activation of a family of murine peroxisome proliferator activated receptors Proc Natl Acad Sci USA 91 1994 7355 7359
5. T. Lemberger, B. Desvergne, and W. Wahli Peroxisome proliferatoractivated receptors: a nuclear receptor signaling pathway in lipid physiology Annu Rev Cell Dev Biol 12 1996 335 363
6. W. Wahli, O. Braissant, and B. Desvergne Peroxisome proliferator activated receptors: transcriptional regulators of adipogenesis, lipid metabolism and more... Chem Biol 2 1995 261 266
7. A. Chawla, E. Schwarz, D. Dimaculangan, and M. Lazar Peroxisome proliferator-activated receptor (PPAR) gamma: adipose-predominant expression and induction early in adipocyte differentiation Endocrinology 135 1994 798 800
8. P. Tontonoz, R.A. Graves, and A.I. Budavari Adipocyte-specific transcription factor ARF6 is a heterodimeric complex of two nuclear hormone receptors, PPAR gamma and RXR alpha Nucleic Acids Res 22 1994 5628 5634
9. R. Brun, J. Kim, E. Hu, and B. Spiegelman Peroxisome proliferators activated receptor gamma and the control of adipogenesis Curr Opin Lipidol 8 1997 212 218
10. B. Spiegelman PPAR-gamma: adipogenic regulator and thiazolidinedione receptor Diabetes 47 1998 507 514
11. D. Bishop-Bailey, and T. Hla Endothelial cell apoptosis induced by the peroxisome proliferator-activated receptor (PPAR) ligand 15-deoxy-delta12, 14-prostaglandin J2 J Biol Chem 274 1999 17042 17048
12. G. Chinetti, S. Griglio, and M. Antonucci Activation of proliferators activated receptors alpha and gamma induces apoptosis of human monocyte-derived macrophages J Biol Chem 273 1998 25573 25580
13. N. Marx, G. Sukhova, C. Murphy, P. Libby, and J. Plutzky Macrophages in human atheroma contain PPARgamma: differentiation-dependent peroxisomal proliferator-activated receptor gamma (PPARgamma) expression and reduction of MMP-9 activity through PPARgamma activation in mononuclear phagocytes in vitro Am J Pathol 153 1998 17 23
14. C. Jiang, A.T. Ting, and B. Seed PPAR-gamma agonists inhibit production of monocyte inflammatory cytokines Nature 391 1998 82 86
15. M. Ricote, A.C. Li, T.M. Willson, C.J. Kelly, and C.K. Glass The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation Nature 391 1998 79 82
16. M.E. Greene, B. Blumberg, and O.W. McBride Isolation of the human peroxisome proliferator activated receptor gamma cDNA: expression in hematopoietic cells and chromosomal mapping Gene Expr 4 1995 281 299
17. X.Y. Yang, L.H. Wang, and T. Chen Activation of human T lymphocytes is inhibited by peroxisome proliferator-activated receptor gamma (PPARgamma) agonists PPARgamma co-association with transcription factor NFAT J Biol Chem 275 2000 4541 4544
18. R.B. Clark, D. Bishop-Bailey, T. Estrada-Hernandez, T. Hla, L. Puddington, and S.J. Padula The nuclear receptor PPAR gamma and immunoregulation: PPAR gamma mediates inhibition of helper T cell responses J Immunol 164 2000 1364 1371
19. J. Padilla, K. Kaur, H.J. Cao, T.J. Smith, and R.P. Phipps Peroxisome proliferator activator receptor-gamma agonists and 15-deoxy-delta(12,14)(12,14)- PGJ(2) induce apoptosis in normal and malignant B-lineage cells J Immunol 165 2000 6941 6948
20. J. Padilla, E. Leung, and R.P. Phipps Human B lymphocytes and B lymphomas express PPAR-gamma and are killed by PPAR-gamma agonists Clin Immunol 103 2002 22 33
21. J. Padilla, K. Kaur, S.G. Harris, and R.P. Phipps PPAR Peroxisome proliferator-activated receptor-gamma haploinsufficiency enhances B cell proliferative responses and exacerbates experimentally induced arthritis-gamma-mediated regulation of normal and malignant B lineage cells Ann N Y Acad Sci 905 2000 97 109
22. J.J. Schlezinger, G.J. Howard, and C.H. Hurst Environmental and endogenous peroxisome proliferator-activated receptor gamma agonists induce bone marrow B cell growth arrest and apoptosis: interactions between mono(2-ethylhexyl)phthalate, 9-cis-retinoic acid, and 15-deoxy-delta12,14- prostaglandin J2 J Immunol 173 2004 3165 3177
23. X. Zhang, M.C. Rodriguez-Galan, and J.J. Subleski Peroxisome proliferator-activated receptor-gamma and its ligands attenuate biologic functions of human natural killer cells Blood 104 2004 3276 3284
24. C. Faveeuw, S. Fougeray, and V. Angeli Peroxisome proliferator-activated receptor gamma activators inhibit interleukin-12 production in murine dendritic cells FEBS Lett 486 2000 261 266
25. P. Gosset, A.S. Charbonnier, and P. Delerive Peroxisome proliferator-activated receptor gamma activators affect the maturation of human monocyte-derived dendritic cells Eur J Immunol 31 2001 2857 2865
26. P. Tontonoz, S. Singer, and B.M. Forman Terminal differentiation of human liposarcoma cells induced by ligands for peroxisome proliferator-activated receptor gamma and the retinoid X receptor Proc Natl Acad Sci USA 94 1997 237 241
27. G.D. Demetri, C.D. Fletcher, and E. Mueller Induction of solid tumor differentiation by the peroxisome proliferator-activated receptor-gamma ligand troglitazone in patients with liposarcoma Proc Natl Acad Sci USA 96 1999 3951 3956
28. T. Kubota, K. Koshizuka, and E.A. Williamson Ligand for peroxisome proliferator-activated receptor gamma (troglitazone) has potent antitumor effect against human prostate cancer both in vitro and in vivo Cancer Res 58 1998 3344 3352
29. E. Mueller, M. Smith, and P. Sarraf Effects of ligand activation of peroxisome proliferator-activated receptor gamma in human prostate cancer Proc Natl Acad Sci USA 97 2000 10990 10995
30. R. Yoshimura, M. Matsuyama, and T. Hase The effect of peroxisome proliferator-activated receptor-gamma ligand on urological cancer cells Int J Mol Med 12 2003 861 865
31. J. Brockman, R. Gupta, and R. Dubois Activation of PPARgamma leads to inhibition of anchorage-independent growth of human colorectal cancer cells Gastroenterology 115 1998 1049 1055
32. P. Sarraf, E. Mueller, and D. Jones Differentiation and reversal of malignant changes in colon cancer through PPARgamma Nat Med 4 1998 1046 1052
33. S. Kitamura, Y. Miyazaki, Y. Shinomura, S. Kondo, S. Kanayama, and Y. Matsuzawa Peroxisome proliferator-activated receptor gamma induces growth arrest and differentiation markers of human colon cancer cells Jpn J Cancer Res 90 1999 75 80
34. W.L. Yang, and H. Frucht Activation of the PPAR pathway induces apoptosis and COX-2 inhibition in HT-29 human colon cancer cells Carcinogenesis 22 2001 1379 1383
35. E. Elstner, C. Muller, and K. Koshizuka Ligands for peroxisome proliferator-activated receptor gamma and retinoic acid receptor inhibit growth and induce apoptosis of human breast cancer cells in vitro and in BNX mice Proc Natl Acad Sci USA 95 1998 8806 8811
36. M. Kilgore, P. Tate, S. Rai, E. Sengoku, and T. Price MCF-7 and T47D human breast cancer cells contain a functional peroxisomal response Mol Cell Endocrinol 129 1997 229 235
37. E. Mueller, P. Sarraf, and P. Tontonoz Terminal differentiation of human breast cancer through PPAR gamma Mol Cell 1 1998 465 470
38. N. Takahashi, T. Okumura, W. Motomura, Y. Fujimoto, I. Kawabata, and Y. Kohgo Activation of PPAR gamma inhibits cell growth and induces apoptosis in human gastric cancer cells FEBS Lett 455 1999 135 139
39. H. Sato, S. Ishihara, and K. Kawashima Expression of peroxisome proliferator-activated receptor (PPAR) gamma in gastric cancer and inhibitory effects of PPAR gamma agonists Br J Cancer 83 2000 1394 1400
40. T. Chang, and E. Szabo Induction of differentiation and apoptosis by ligands of peroxisome proliferator-activated receptor gamma in non-small cell lung cancer Cancer Res 60 2000 1129 1138
41. Y. Tsubouchi, H. Sano, and Y. Kawahito Inhibition of human lung cancer cell growth by the peroxisome proliferator-activated receptor-gamma agonists through induction of apoptosis Biochem Biophys Res Commun 270 2000 400 405
42. W. Motomura, T. Okumura, N. Takahashi, T. Obara, and Y. Kohgo Activation of peroxisome proliferator-activated receptor gamma by troglitazone inhibits cell growth through the increase of p27KiP1 in human pancreatic carcinoma cells Cancer Res 60 2000 5558 5564
43. A. Elnemr, T. Ohta, and K. Iwata PPARgamma ligand (thiazolidinedione) induces growth arrest and differentiation markers of human pancreatic cancer cells Int J Oncol 17 2000 1157 1164
44. A. Itami, G. Watanabe, and Y. Shimada Ligands for peroxisome proliferator-activated receptor gamma inhibit growth of pancreatic cancers both in vitro and in vivo Int J Cancer 94 2001 370 376
45. G. Eibl, M.N. Wente, H.A. Reber, and O.J. Hines Peroxisome proliferator-activated receptor gamma induces pancreatic cancer cell apoptosis Biochem Biophys Res Commun 287 2001 522 529
46. J.A. Keelan, T.A. Sato, K.W. Marvin, J. Lander, R.S. Gilmour, and M.D. Mitchell 15-Deoxy-delta(12,14)-prostaglandin J(2), a ligand for peroxisome proliferator-activated receptor-gamma, induces apoptosis in JEG3 choriocarcinoma cells Biochem Biophys Res Commun 262 1999 579 585
47. N. Chattopadhyay, D.P. Singh, and O. Heese Expression of peroxisome proliferator-activated receptors (PPARS) in human astrocytic cells: PPAR gamma agonists as inducers of apoptosis J Neurosci Res 61 2000 67 74
48. T. Zander, J.A. Kraus, and C. Grommes Induction of apoptosis in human and rat glioma by agonists of the nuclear receptor PPAR gamma J Neurochem 81 2002 1052 1060
49. N.G. Nikitakis, C. Hebert, M.A. Lopes, M.A. Reynolds, and J.J. Sauk PPAR gamma-mediated antineoplastic effect of NSAID sulindac on human oral squamous carcinoma cells Int J Cancer 98 2002 817 823
50. E. Lucarelli, L. Sangiorgi, and V. Maini Troglitazione affects survival of human osteosarcoma cells Int J Cancer 98 2002 344 351
51. K. Ohta, T. Endo, K. Haraguchi, J.M. Hershman, and T. Onaya Ligands for peroxisome proliferator-activated receptor gamma inhibit growth and induce apoptosis of human papillary thyroid carcinoma cells J Clin Endocrinol Metab 86 2001 2170 2177
52. M. Date, K. Fukuchi, S. Morita, H. Takahashi, and K. Ohura 15-Deoxy-delta12,14-prostaglandin J2, a ligand for peroxisome proliferators-activated receptor-gamma, induces apoptosis in human hepatoma cells Liver Int 23 2003 460 466
53. C. Han, A.J. Demetris, G.K. Michalopoulos, Q. Zhan, J.H. Shelhamer, and T. Wu PPAR gamma ligands inhibit cholangiocarcinoma cell growth through p53-dependent GADD45 and p21 pathway Hepatology 38 2003 167 177
54. M.A. Rumi, H. Sato, and S. Ishihara Peroxisome proliferator-activated receptor gamma ligand-induced growth inhibition of human hepatocellular carcinoma Br J Cancer 84 2001 1640 1647
55. H. Koga, S. Sakisaka, and M. Harada Involvement of p21 (WAF1/Cip1), p27(Kip1), and p18(INK4c) in troglitazone-induced cell-cycle arrest in human hepatoma cell lines Hepatology 33 2001 1087 1097
56. T. Takashima, Y. Fujiwara, and K. Higuchi PPAR-gamma ligands inhibit growth of human esophageal adenocarcinoma cells through induction of apoptosis, cell cycle arrest and reduction of ornithine decarboxylase activity Int J Oncol 19 2001 465 471
57. G. Muzio, M. Maggiora, and A. Trombetta Mechanisms involved in growth inhibition induced by clofibrate in hepatoma cells Toxicology 187 2003 149 159
58. M. Toyoda, H. Takagi, and N. Horiguchi A ligand for peroxisome proliferator-activated receptor gamma inhibits cell growth and induces apoptosis in human liver cancer cells Gut 50 2002 563 567
59. R. Yoshimura, M. Matsuyama, and Y. Segawa Expression of peroxisome proliferator-activated receptors (PPARs) in human urinary bladder carcinoma and growth inhibition by its agonists Int J Cancer 104 2003 597 602
60. Y.F. Guan, Y.H. Zhang, R.M. Breyer, L. Davis, and M.D. Breyer Expression of peroxisome proliferator-activated receptor gamma (PPAR-γamma) in human transitional bladder cancer and its role in inducing cell death Neoplasia 1 1999 330 339
61. S.W. Han, M.E. Greene, J. Pitts, R.K. Wada, and N. Sidell Novel expression and function of peroxisome proliferator-activated receptor gamma (PPAR-γamma) in human neuroblastoma cells Clin Cancer Res 7 2001 98 104
62. H. Asou, W. Verbeek, and E. Williamson Growth inhibition of myeloid leukemia cells by troglitazone, a ligand for peroxisome proliferator activated receptor gamma, and retinoids Int J Oncol 15 1999 1027 1031
63. C. Zang, H. Liu, and M.G. Posch Peroxisome proliferator-activated receptor gamma ligands induce growth inhibition and apoptosis of human B lymphocytic leukemia Leuk Res 28 2004 387 397
64. Y. Azuma, K. Watanabe, M. Date, M. Daito, and K. Ohura Induction of proliferation by 15-deoxy-delta12,14-prostaglandin J2 and the precursors in monocytic leukemia U937 Pharmacology 71 2004 181 191
65. S. Inoue, R.T. Snowden, M.J. Dyer, and G.M. Cohen CDDO induces apoptosis via the intrinsic pathway in lymphoid cells Leukemia 18 2004 948 952
66. J.J. Liu, R.W. Huang, and D.J. Lin Expression of survivin and bax/bcl-2 in peroxisome proliferator activated receptor-{gamma} ligands induces apoptosis on human myeloid leukemia cells in vitro Ann Oncol 16 2005 455 459
67. M. Konopleva, E. Elstner, and T.J. McQueen Peroxisome proliferator-activated receptor gamma and retinoid X receptor ligands are potent inducers of differentiation and apoptosis in leukemias Mol Cancer Ther 3 2004 1249 1262
68. N. Yamakawa-Karakida, K. Sugita, and T. Inukai Ligand activation of peroxisome proliferator-activated receptor gamma induces apoptosis of leukemia cells by down-regulating the c-myc gene expression via blockade of the Tcf-4 activity Cell Death Differ 9 2002 513 526
69. D.M. Ray, S.H. Bernstein, and R.P. Phipps Human multiple myeloma cells express peroxisome proliferator-activated receptor gamma and undergo apoptosis upon exposure to PPARgamma ligands Clin Immunol 113 2004 203 213
70. P. Tontonoz, L. Nagy, J.G. Alvarez, V.A. Thomazy, and R.M. Evans PPARgamma promotes monocyte/macrophage differentiation and uptake of oxidized LDL Cell 93 1998 241 252
71. B.A. Beamer, C. Negri, and C.J. Yen Chromosomal localization and partial genomic structure of the human peroxisome proliferator activated receptor-γ (hPPARγ) gene Biochem Biophys Res Commun 233 1997 756 759
72. Y. Zhu, C. Qi, and J.R. Korenberg Structural organization of mouse peroxisome proliferatoractivated receptor γ (mPPAR γ) gene: alternative promoter use and different splicing yield two mPPARgisoforms Proc Natl Acad Sci USA 92 1995 7921 7925
73. L. Fajas, D. Auboeuf, and E. Raspe The organization, promoter analysis, and expression of the human PPAR-γ gene J Biol Chem 272 1997 18779 18789
74. L. Fajas, J.C. Fruchart, and J. Auwerx PPARgamma3 mRNA: a distinct PPARγ mRNA subtype transcribed from an independent promoter FEBS Lett 438 1998 55 60
75. H. Sundvold, and S. Lien Identification of a novel peroxisome proliferator-activated receptor (PPAR) gamma promoter in man and transactivation by the nuclear receptor RORalpha1 Biochem Biophys Res Commun 287 2001 383 390
76. C. Grommes, G.E. Landreth, and M.T. Heneka Antineoplastic effects of peroxisome proliferator-activated receptor gamma agonists Lancet Oncol 5 2004 419 429
77. T.M. Willson, P.J. Brown, D.D. Sternbach, and B.R. Henke The PPARs: from orphan receptors to drug discovery J Med Chem 43 2000 527 550
78. B. Forman, P. Tontonoz, J. Chen, R. Brun, B. Spiegelman, and R. Evans 15-Deoxy-delta 12, 14-prostaglandin J2 is a ligand for the adipocyte determination factor PPAR gamma Cell 83 1995 803 812
79. M.J. Reginato, S.L. Krakow, S.T. Bailey, and M.A. Lazar Prostaglandins promote and block adipogenesis through opposing effects on peroxisome proliferator-activated receptor gamma J Biol Chem 273 1998 1855 1858
80. K.L. Houseknecht, B.M. Cole, and P.J. Steele Peroxisome proliferator-activated receptor gamma (PPARgamma) and its ligands: a review Domest Anim Endocrinol 22 2002 1 23
81. M.B. Debril, J.P. Renaud, L. Fajas, and J. Auwerx The pleiotropic functions of peroxisome proliferator-activated receptor gamma J Mol Med 79 2001 30 47
82. K. Schoonjans, B. Staels, and J. Auwerx Role of the peroxisome proliferator-activated receptor (PPAR) in mediating the effects of fibrates and fatty acids on gene expression J Lipid Res 37 1996 907 925
83. D. Shao, S.M. Rangwala, S.T. Bailey, S.L. Krakow, M.J. Reginato, and M.A. Lazar Interdomain communication regulating ligand binding by PPAR-gamma Nature 396 1998 377 380
84. Y. Kodera, K. Takeyama, A. Murayama, M. Suzawa, Y. Masuhiro, and S. Kato Ligand type-specific interactions of peroxisome proliferator-activated receptor gamma with transcriptional coactivators J Biol Chem 275 2000 33201 33204
85. J.W. Lee, Y.C. Lee, S.-Y. Na, D.-J. Jung, and S.-K. Lee Transcriptional co-regulators of the nuclear receptor superfamily: coactivators, and co-repressors Cell Mol Life Sci 58 2001 289 297
86. B. Desvergne, and W. Wahli Peroxisome proliferator-activated receptors: nuclear control of metabolism Endocr Rev 20 1999 649 688
87. S.M. Rangwala, and M.A. Lazar Peroxisome proliferator-activated receptor gamma in diabetes and metabolism Trends Pharmacol Sci 25 2004 331 336
88. G. Chinetti, J.C. Fruchart, and B. Staels Peroxisome proliferator- activated receptors (PPARs): nuclear receptors at the crossroads between lipid metabolism and inflammation Inflamm Res 49 2000 497 505
89. R.P. Warrell Jr., S.R. Frankel, and W.H. Miller Jr. Differentiation therapy of acute promyelocytic leukemia with tretinoin (all-trans-retinoic acid) N Engl J Med 324 1991 1385 1393
90. W.K. Hong, S.M. Lippman, and L.M. Itri Prevention of second primary tumors with isotretinoin in squamous-cell carcinoma of the head and neck N Engl J Med 323 1990 795 801
91. S.M. Lippman, J.J. Kavanagh, and M. Paredes-Espinoza 13-cis-Retinoic acid plus interferon alpha-2a: highly active systemic therapy for squamous cell carcinoma of the cervix J Natl Cancer Inst 84 1992 241 245
92. S.M. Lippman, D.R. Parkinson, and L.M. Itri 13-cis-Retinoic acid and interferon alpha-2a: effective combination therapy for advanced squamous cell carcinoma of the skin J Natl Cancer Inst 84 1992 235 241
93. S. Kawa, T. Nikaido, H. Unno, N. Usuda, K. Nakayama, and K. Kiyosawa Growth inhibition and differentiation of pancreatic cancer cell lines by PPAR gamma ligand troglitazone Pancreas 24 2002 1 7
94. M. Toyota, Y. Miyazaki, and S. Kitamura Peroxisome proliferator-activated receptor gamma reduces the growth rate of pancreatic cancer cells through the reduction of cyclin D1 Life Sci 70 2002 1565 1575
95. F. Yin, S. Wakino, and Z. Liu Troglitazone inhibits growth of MCF-7 breast carcinoma cells by targeting G1 cell-cycle regulators Biochem Biophys Res Commun 286 2001 916 922
96. J. Shao, H. Sheng, and R.N. DuBois Peroxisome proliferator-activated receptors modulate K-Ras-mediated transformation of intestinal epithelial cells Cancer Res 62 2002 3282 3288
97. H. Sheng, J. Shao, and R.N. DuBois Akt/PKB activity is required for Ha-Ras-mediated transformation of intestinal epithelial cells J Biol Chem 276 2001 14498 14504
98. P. Rodriguez-Viciana, P.H. Warne, and A. Khwaja Role of phosphoinositide 3-OH kinase in cell transformation and control of the actin cytoskeleton by Ras Cell 89 1997 457 467
99. M. Osada, T. Tolkacheva, and W. Li Differential roles of Akt, Rac, and Ral in R-Ras-mediated cellular transformation, adhesion, and survival Mol Cell Biol 19 1999 6333 6344
100. J.P. Vanden Heuvel Peroxisome proliferator-activated receptors: a critical link among fatty acids, gene expression and carcinogenesis J Nutr 129 1999 575S 580S
101. L. Patel, I. Pass, P. Coxon, C.P. Downes, S.A. Smith, and C.H. Macphee Tumor suppressor and anti-inflammatory actions of PPARgamma agonists are mediated via upregulation of PTEN Curr Biol 11 2001 764 768
102. T. Shimada, K. Kojima, K. Yoshiura, H. Hiraishi, and A. Terano Characteristics of the peroxisome proliferator-activated receptor gamma (PPAR-γ) ligand-induced apoptosis in colon cancer cells Gut 50 2002 658 664
103. Y. Kim, N. Suh, M. Sporn, and J.C. Reed An inducible pathway for degradation of FLIP protein sensitizes tumor cells to TRAIL-induced apoptosis J Biol Chem 277 2002 22320 22329
104. J. Folkman Angiogenesis in cancer, vascular, rheumatoid and other disease Nat Med 1 1995 27 31
105. J. Folkman How is blood vessel growth regulated in normal and neoplastic tissue? G.H.A. Clowes memorial award lecture Cancer Res 46 1986 467 473
106. L.A. Liotta, P.S. Steeg, and W.G. Stetler-Stevenson Cancer metastasis and angiogenesis: an imbalance of positive and negative regulation Cell 64 1991 327 336
107. A.J. Hayes, L.Y. Li, and M.E. Lippman Science, medicine, and the future. Antivascular therapy: a new approach to cancer treatment BMJ 318 1999 853 856
108. T. Boehm, J. Folkman, T. Browder, and M.S. O'Reilly Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance Nature 390 1997 404 407
109. M.S. O'Reilly, T. Boehm, and Y. Shing Endostatin: an endogenous inhibitor of angiogenesis and tumor growth Cell 88 1997 277 285
110. X. Xin, S. Yang, J. Kowalski, and M.E. Gerritsen Peroxisome proliferator-activated receptor gamma ligands are potent inhibitors of angiogenesis in vitro and in vivo J Biol Chem 274 1999 9116 9121
111. Y. Barak, M.C. Nelson, and E.S. Ong PPAR gamma is required for placental, cardiac, and adipose tissue development Mol Cell 4 1999 585 595
112. T. Murata, S. He, and M. Hangai Peroxisome proliferator-activated receptor-gamma ligands inhibit choroidal neovascularization Invest Ophthalmol Vis Sci 41 2000 2309 2317
113. D. Panigrahy, S. Singer, and L.Q. Shen PPARgamma ligands inhibit primary tumor growth and metastasis by inhibiting angiogenesis J Clin Invest 110 2002 923 932
114. Y. Sassa, Y. Hata, L.P. Aiello, Y. Taniguchi, K. Kohno, and T. Ishibashi Bifunctional properties of peroxisome proliferator-activated receptor gamma1 in KDR gene regulation mediated via interaction with both Sp1 and Sp3 Diabetes 53 2004 1222 1229
115. M.R. Sierra-Honigmann, A.K. Nath, and C. Murakami Biological action of leptin as an angiogenic factor Science 281 1998 1683 1686
116. J. Rieusset, J. Auwerx, and H. Vidal Regulation of gene expression by activation of the peroxisome proliferator-activated receptor gamma with rosiglitazone (BRL 49653) in human adipocytes Biochem Biophys Res Commun 265 1999 265 271
117. S. Goetze, A. Bungenstock, and C. Czupalla Leptin induces endothelial cell migration through Akt, which is inhibited by PPARgamma-ligands Hypertension 40 2002 748 754
118. L. Possati, R. Rocchetti, and S. Talevi The role of peroxisome proliferator-activated receptor gamma in bladder cancer in relation to angiogenesis and progression Gen Pharmacol 35 2000 269 275
119. T.G. Kroll, P. Sarraf, and L. Pecciarini PAX8-PPARgamma1 fusion oncogene in human thyroid carcinoma Science 289 2000 1357 1360
120. P. Sarraf, E. Mueller, and W.M. Smith Loss-of-function mutations in PPAR gamma associated with human colon cancer Mol Cell 3 1999 799 804
121. S. Kawano, C.W. Miller, and A.F. Gombart Loss of p73 gene expression in leukemias/lymphomas due to hypermethylation Blood 94 1999 1113 1120
122. T. Ikezoe, C.W. Miller, and S. Kawano Mutational analysis of the peroxisome proliferator-activated receptor gamma gene in human malignancies Cancer Res 61 2001 5307 5310
123. S. Fauconnet, I. Lascombe, and E. Chabannes Differential regulation of vascular endothelial growth factor expression by peroxisome proliferator- activated receptors in bladder cancer cells J Biol Chem 277 2002 23534 23543
124. E. Saez, P. Tontonoz, and M.C. Nelson Activators of the nuclear receptor PPARgamma enhance colon polyp formation Nat Med 4 1998 1058 1061
125. A.M. Lefebvre, I. Chen, and P. Desreumaux Activation of the peroxisome proliferator-activated receptor gamma promotes the development of colon tumors in C57BL/6J-APCMin/+ mice Nat Med 4 1998 1053 1057
126. M. Shtutman, J. Zhurinsky, and I. Simcha The cyclin D1 gene is a target of the beta-catenin/LEF-1 pathway Proc Natl Acad Sci USA 96 1999 5522 5527
127. T.C. He, A.B. Sparks, and C. Rago Identification of c-myc as a target of the APC pathway Science 281 1998 1509 1512
128. S.M. Powell, N. Zilz, and Y. Beazer-Barclay APC mutations occur early during colorectal tumorigenesis Nature 359 1992 235 237
129. E. Saez, J. Rosenfeld, and A. Livolsi PPAR gamma signaling exacerbates mammary gland tumor development Genes Dev 18 2004 528 540
130. G. Debrock, V. Vanhentenrijk, R. Sciot, M. Debiec-Rychter, R. Oyen, and A. Van Oosterom A phase II trial with rosiglitazone in liposarcoma patients Br J Cancer 89 2003 1409 1412
131. J.I. Hisatake, T. Ikezoe, M. Carey, S. Holden, S. Tomoyasu, and H.P. Koeffler Down-regulation of prostate-specific antigen expression by ligands for peroxisome proliferator-activated receptor gamma in human prostate cancer Cancer Res 60 2000 5494 5498
132. H.J. Burstein, G.D. Demetri, E. Mueller, P. Sarraf, B.M. Spiegelman, and E.P. Winer Use of the peroxisome proliferator-activated receptor (PPAR) gamma ligand troglitazone as treatment for refractory breast cancer: a phase II study Breast Cancer Res Treat 79 2003 391 397
133. N. Hirase, T. Yanase, and Y. Mu Thiazolidinedione induces apoptosis and monocytic differentiation in the promyelocytic leukemia cell line HL60 Oncology 57 Suppl. 2 1999 17 26
134. S. Fujimura, J. Suzumiya, K. Nakamura, and J. Ono Effects of troglitazone on the growth and differentiation of hematopoietic cell lines Int J Oncol 13 1998 1263 1267
135. A. Sugimura, Y. Kiriyama, and H. Nochi Troglitazone suppresses cell growth of myeloid leukemia cell lines by induction of p21WAF1/CIP1 cyclin-dependent kinase inhibitor Biochem Biophys Res Commun 261 1999 833 837
136. S.A. Hamadani, T. Zhang, C. Dorrell, J. Dick, R. Wells, and S. Kamel-Reid X-retinoic acid receptor a fusion genes in acute promyelocytic leukemia interfere with retinoid and peroxisomeproliferator signaling pathways Blood 98 2001 88a [abstract]
137. C. Denzlinger, K. Dittman, and A. Mohle Peroxisome proliferator activated receptor γ (PPAR-γ) agonists as antileukemic agents in CMML Blood 98 2001 625a [abstract]
138. U. Kintscher, S. Goetze, and S. Wakino Peroxisome proliferator-activated receptor and retinoid X receptor ligands inhibit monocyte chemotactic protein-1-directed migration of monocytes Eur J Pharmacol 401 2000 259 270
139. C. Zang, A. Kluegel, and M. Porsch Peroxisome proliferator-activated receptor γ ligands induce growth inhibition and apoptosis of human lymphocytic leukemia in vitro Blood 98 2001 104a [abstract]
140. B. Johansson, R. Billstrom, and U. Kristoffersson Deletion of chromosome arm 3p in hematologic malignancies Leukemia 11 1997 1207 1213
141. M.E. Greene, J. Pitts, and M.A. McCarville PPAR-γ: observations in the hematopoietic system Prostaglandins Other Lipid Mediat 62 2000 45 73
142. A. Deldar, G. Williams, and C. Stevens Pathogenesis of thiazolidinedione induced hematotoxicity in the dog Diabetes 42 Suppl. 1993 179 187
143. G.D. Williams, A. Deldar, W.H. Jordan, C. Gries, G. Long, and R.D. Dimarchi Subchronic toxicity of the thiazolidinedione, Tanabe-174 (Ly282449) in the rat and dog Diabetes 42 Suppl. 1993 186 195
144. K. Kosaka, T. Kuzuya, H. Akanuma, Y. Shigeta, and T. Kaneko Clinical evaluation of a new oral hypoglycemic drug Cs-045 in patients with non-insulin dependent diabetes mellitus poorly controlled by sulfonylureas. A double-blind, placebo-controlled study Rinsho Igaku 9 Suppl. 1993 19 37
145. J.M. Gimble, C.E. Robinson, and X. Wu Peroxisome proliferator-activated receptor-activation by thiazolidinediones induces adipogenesis in bone marrow stromal cells Mol Pharmacol 50 1996 1087 1094
146. N. Hirase, T. Yanase, and Y. Mu Thiazolidinedione suppresses the expression of erythroid phenotype in erythroleukemia cell line K562 Leuk Res 24 2000 393 400